Prevention Research

Vincent Robinson, MD

RE-LY

• Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses Dabigatran Etexilate with Open Label Warfarin for the Prevention of Stroke and Systemic Embolic Events in Patients with Non-Vulvular Atrial Fibrillation.  A Prospective, Randomized, Open Label, Active Controlled, Multicenter, Parallel-Group Non-Inferiority Trial (RE-LY STUDY)

EXCLAIM

• A Double-Blind, Placebo-Controlled, Parallel, Multicenter Study on Extended VTE Prophylaxis in Acutely Ill Medical Patients with Prolonged Immobilization. (EXCLAIM)

MO5-749

• A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Simvastatin Combination Therapy to Fenofibric Acid and Simvastatin Monotherapy in Subjects with Mild Dyslipidemia.

MO5-758

• A Long-Term, Open-label, Safety Extension Study of the Combination of Fenofibric Acid and Statin Therapy for Subjects with Mixed Dyslipidemia. 

BAY 597939 and Warfarin

• A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-   Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 597939) with Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects with Non-Valvular Atrial Fibrillation.